Serum free thyroid hormones in subclinical hypothyroidism

Area of Science:

• Endocrinology
• Thyroid Disorders
• Clinical Diagnostics

Background:

• Subclinical hypothyroidism (SH) is characterized by elevated thyroid-stimulating hormone (TSH) with normal free thyroxine (FT4) and free triiodothyronine (FT3) levels.
• Distinguishing true SH from early-stage overt hypothyroidism is crucial for timely intervention.

Purpose of the Study:

• To evaluate the diagnostic utility of serum free thyroxine (FT4) and free triiodothyronine (FT3) in patients with subclinical hypothyroidism (SH).
• To determine if FT4 and FT3 measurements improve the diagnosis of impending thyroid failure.

Main Methods:

• Serum FT4 and FT3 concentrations were measured in 52 patients with SH and 52 matched controls.
• SH was defined by normal total T4 (TT4), total T3 (TT3), FT4, and FT3 indices with elevated TSH, and absence of hypothyroid symptoms.
• The Galen and Gambino predictive value model was used for analysis.

Main Results:

• Patients with SH showed significantly lower mean FT4 (6.1 +/- 1.6 pg/ml) and FT3 (3.1 +/- 0.7 pg/ml) compared to controls.
• Low FT4 levels were observed in 33/52 SH patients, and low FT3 in 8/52.
• FT4 demonstrated higher sensitivity but lower specificity than FT3 for diagnosing SH.

Conclusions:

• Measuring FT4 in addition to TSH is recommended for diagnosing impending thyroid failure.
• Many patients diagnosed with SH may already have mild hypothyroidism, indicated by reduced FT4 levels.